Nexus Pharmaceuticals has launched its patent-pending New Drug Application (NDA) Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10 mL vial.

With no need for compounding, diluting, or mixing, Emerphed saves valuable staff time while also reducing the potential for ...

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest aggregate and particle identification system, called Aura™.

Aura is the next generation of the Horizon^®, Halo Labs' popular Backgrounded Membrane Imaging ...

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today that its SARS-CoV-2 IgG antibody test, Babson Diagnostics aC19G1, has received emergency use authorization (EUA) from the Food and Drug Administration (FDA).

Babson Diagnostics aC19G1 is a COVID-19 ...

When providing medical information online, enhanced user experienceis key to deliveringreal value according to digital medical publisher EPG Health.

Such is their reason for launching Medthority,to replacethe company’spreviouswebsite for healthcare professionals(HCPs), epgonline.org.

...

Genetworx Laboratories, a leading innovative molecular diagnostic testing laboratory, announced today that the company is now performing COVID-19 antibody testing, in addition to diagnostic testing, for the virus.

The Virginia-based company stated that it is providing the new antibody blood ...

Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. ("AstraZeneca") to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222...